World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
83
Citations
47409
World Ranking
953
National Ranking
438

Medicine

D-Index
83
Citations
47921
World Ranking
15347
National Ranking
7739

Research.com Recognitions

  • 1999 - Member of the National Academy of Medicine (NAM)
  • 1995 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Paul A. Volberding is affiliated with the University of California, San Francisco in the United States. Their primary field of study is Medicine, with a particular focus on infectious diseases, epidemiology, virology, emergency medicine, and hepatology.

Their research work centers largely on HIV/AIDS-related topics. The main areas covered include HIV/AIDS research and interventions, HIV research and treatment, HIV-related health complications and treatments, HIV, drug use, sexual risk, HIV/AIDS drug development and treatment, as well as hepatitis C and B virus studies.

Volberding has published extensively in various scientific venues, with notable frequent publications appearing in UNC Libraries, AIDS and Behavior, JAMA, Proceedings of the National Academy of Sciences, and BMC Infectious Diseases.

Selected recent papers by Volberding include:

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults (2020, JAMA)
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel (2020, UNC Libraries)
  • HIV post-treatment controllers have distinct immunological and virological features (2023, Proceedings of the National Academy of Sciences)
  • Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study (2020, BMC Infectious Diseases)
  • The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system (2021, Drug and Alcohol Dependence)

Frequent co-authors who have collaborated with Volberding include:

  • Joseph J. Eron
  • Michael S. Saag
  • Jonathan Z. Li
  • Rajesh T. Gandhi
  • Elizabeth Connick

Volberding's contributions span important subfields such as infectious diseases, epidemiology, and virology. Their work often addresses overlapping topics in HIV treatment and management, as well as associated health concerns in affected populations.

The scientist has been recognized by several institutions. Awards include membership in the National Academy of Medicine since 1999, fellowship of the American Association for the Advancement of Science awarded in 1995, and membership in the Association of American Physicians.

Best Publications

  • The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial.

    Margaret A Fischl;D. D. Richman;M. H. Grieco;M. S. Gottlieb

  • Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents

    A. S. Fauci;J. G. Bartlett;E. P. Goosby;M. D. Smith

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter

    Paul A. Volberding;Stephen W. Lagakos;Matthew A. Koch;David K. Booth

  • The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

    Unknown

  • Non-Hodgkin's Lymphoma in 90 Homosexual Men: Relation to Generalized Lymphadenopathy and the Acquired Immunodeficiency Syndrome

    John L. Ziegler;Jay A. Beckstead;Paul A. Volberding;Donald I. Abrams

  • Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell

  • Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

    Raymond T. Chung;Janet Andersen;Paul Volberding;Gregory K. Robbins

  • Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel

    Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner

  • Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society—USA Panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel

    Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper

  • Antiretroviral Therapy for HIV Infection in 1998: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, placebo-controlled trial

    M. A. Fischl;D. D. Richman;N. Hansen;A. C. Collier

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F. Günthard;Michael S. Saag;Constance A. Benson;Carlos del Rio

  • Antiretroviral Treatment of Adult HIV Infection

    Scott M. Hammer;Joseph J. Eron;Peter Reiss;Robert T. Schooley

  • Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • HIV viral load markers in clinical practice

    M S Saag;M Holodniy;D R Kuritzkes;W A O'Brien

  • Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

    Patrick G. Yeni;Scott M. Hammer;Martin S. Hirsch;Michael S. Saag

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

    Michael S. Saag;Constance A. Benson;Rajesh T. Gandhi;Jennifer F. Hoy

  • HIV and aging: State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group

    Kevin P. High;Mark Brennan-Ing;David B. Clifford;Mardge H. Cohen

  • AIDS-Associated Non-Hodgkin's Lymphoma in San Francisco

    Lawrence D. Kaplan;Donald I. Abrams;Ellen Feigal;Michael McGrath

Frequent Co-Authors

Donald I. Abrams
Donald I. Abrams University of California, San Francisco
Margaret A. Fischl
Margaret A. Fischl University of Miami
Michael S. Saag
Michael S. Saag University of Alabama at Birmingham
Robert T. Schooley
Robert T. Schooley University of California, San Diego
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Jerome E. Groopman
Jerome E. Groopman Beth Israel Deaconess Medical Center
Martin S. Hirsch
Martin S. Hirsch Harvard Medical School
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Julio S. G. Montaner
Julio S. G. Montaner University of British Columbia
Derek D. Satre
Derek D. Satre University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various related online degrees and career pathways. For individuals with unique challenges, such as criminal records, exploring the best degree for felons can be an important first step to gaining relevant education and improving employment prospects.

Healthcare careers also complement a microbiology background. For example, becoming a functional medicine np allows professionals to integrate holistic approaches with medical knowledge, benefiting patient care through a deeper understanding of microbiological impacts on health.

For those interested in the administrative side of health sciences, certifications like cpc provide valuable skills in medical coding, essential for accurate health records management and billing processes.

Additionally, careers in health data, such as health information management job description and salary, offer promising opportunities that blend data expertise with healthcare knowledge, making it a smart choice for microbiology graduates seeking diverse roles.

Best Scientists Citing Paul A. Volberding

Trending Scientists

Recently Published Articles